Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06768671 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 6, 2026 (before its estimated September 28, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Mar 27, 2026 to Sep 28, 2026 Trial status: Recruiting to Active, Not Recruiting · Site details revised at 18 of 18 sitesv5 Show 2 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 18 of 18 sites
  2. Study sites: 17 to 18v4
  3. Study sites: 10 to 17v3
  4. Study sites: 1 to 10v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a study to evaluate the pharmacokinetic (PK) and safety of sonelokimab in adolescent patients with HS.
Trial Details
NCT Number NCT06768671
Lead Sponsor MoonLake Immunotherapeutics AG
Conditions Hidradenitis Suppurativa
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov